DEUTSCHES KREBSFORSCHUNGSZENTRUM - Germany 

Ranking results:

Past rankings:

2020
Criterium:Position:
Overall Score:600-700
Total Project Funding per Partner:700-800
Total Number of Projects:500-600
2019
Criterium:Position:
Overall Score:100-200
Total Project Funding per Partner:100-200
Total Number of Projects:200-300
2018
Criterium:Position:
Overall Score:> 1000
Total Project Funding per Partner:> 1000
Total Number of Projects:> 1000
Networking Rank (Reputation):> 1000
2017
Criterium:Position:
Overall Score:300-400
Total Project Funding per Partner:100-200
Total Number of Projects:300-400
Networking Rank (Reputation):600-700
2016
Criterium:Position:
Overall Score:600-700
Total Project Funding per Partner:200-300
Total Number of Projects:500-600
Networking Rank (Reputation):> 1000
2015
Criterium:Position:
Overall Score:200-300
Total Project Funding per Partner:200-300
Total Number of Projects:400-500
Networking Rank (Reputation):> 1000
Partner Constancy:300-400
Project Leadership Index:82
2013
Criterium:Position:
Overall Score:300-400
Total Project Funding per Partner:200-300
Total Number of Projects:64
Total Project Funding:300-400
Partner Constancy:58
Project Leadership Index:47
Diversity Index:47
2012
Criterium:Position:
Overall Score:500-600
Total Project Funding per Partner:100-200
Total Number of Projects:61
Total Project Funding:200-300
Networking Rank (Reputation):300-400
Networking Rank (Reputation):300-400
Partner Constancy:46
Project Leadership Index:75
Diversity Index:37
2011
Criterium:Position:
Overall Score:600-700
Total Project Funding per Partner:400-500
Total Number of Projects:300-400
Total Project Funding:400-500
Networking Rank (Reputation):400-500
Partner Constancy:700-800
Project Leadership Index:200-300
Diversity Index:> 1000
2010
Criterium:Position:
Overall Score:> 1000
Total Project Funding per Partner:100-200
Total Number of Projects:500-600
Total Project Funding:400-500
Networking Rank (Reputation):> 1000
Partner Constancy:500-600
Project Leadership Index:600-700
Diversity Index:> 1000
2009
Criterium:Position:
Overall Score:400-500
Total Project Funding per Partner:100-200
Total Number of Projects:200-300
Total Project Funding:200-300
Networking Rank (Reputation):200-300
Partner Constancy:600-700
Project Leadership Index:600-700
Diversity Index:300-400
2008
Criterium:Position:
Overall Score:300-400
Total Project Funding per Partner:100-200
Total Number of Projects:200-300
Total Project Funding:100-200
Networking Rank (Reputation):200-300
Partner Constancy:200-300
Project Leadership Index:300-400
Diversity Index:> 1000
2007
Criterium:Position:
Overall Score:900-1000
Total Project Funding per Partner:100-200
Total Number of Projects:200-300
Total Project Funding:300-400
Networking Rank (Reputation):400-500
Partner Constancy:500-600
Project Leadership Index:600-700
Diversity Index:> 1000

Ranking timeline:

Project Participation Performance(2010-01-01 - 2024-12-31 ):

Total Project Funding:

Total funding allocated to projects this organisation participated or coordinated

Funding per Partner:

Since 2014 individual funding per partner. If data is not available at CORDIS: total funding / No of participants.

Projects:

Leadership:

Total number of projects: 118
As coordinator: 8
As participant: 77
Sole participant: 33
Coordinator / Participant Ratio: 0.1*

*Ratio includes only projects with > 2 partners

Summary:

Total project funding [€]:Projects [No]:
Year:coordinator*participant*per partner  as coordinatoras participant
2023 3.520.925 35.206.288 5.102.620 2 5
2022 5.001.869 41.761.952 6.626.966 5 7
2021 4.000.394 10.938.370 4.868.111 5 3
2020 300.000 29.884.179 2.519.757 2 5
2019 18.545.451 56.823.039 14.381.875 6 8
2018 5.311.161 15.918.505 3.492.112 5 5
2017 9.376.250 8.759.860 4.500.000 2 4
2016 1.738.955 11.293.830 4.178.127 2 4
2015 2.168.794 38.787.645 6.127.881 2 8
2014 261.969 0 261.969 2
2013 6.195.747 35.879.301 4.334.619 3 7
2012 336.754 46.735.876 9.167.323 2 10
2011 8.098.428 25.638.979 3.387.602 3 5
2010 0 44.806.245 5.263.164 6
*n.b.: These numbers represent the total amount of funds allocated to projects this institution has participated in, not the funding allocated to this institution

Networking:

Partners:

Institution:Projects [No]:
EUROPEAN MOLECULAR BIOLOGY LABORATORY13
UNIVERSITAETSKLINIKUM HEIDELBERG11
IMPERIAL COLLEGE OF SCIENCE TECHNOLOGY AND MEDICINE9
KAROLINSKA INSTITUTE9
STICHTING HET NEDERLANDS KANKER INSTITUUTANTONI VAN LEEUWENHOEK ZIEKENHUIS9
INSTITUT CURIE8
UNIVERSITY COLLEGE LONDON8
CHARITE UNIVERSITAETSMEDIZIN BERLIN7
THE CHANCELLOR MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD7
THE UNIVERSITY OF MANCHESTER7
BARCELONA SUPERCOMPUTING CENTER CENTRO NACIONAL DE SUPERCOMPUTACION6
CENTRE DE REGULACIO GENOMICA6
CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE6
ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM6
RUPRECHT KARLS UNIVERSITAET HEIDELBERG6
UNIVERSITAIR MEDISCH CENTRUM UTRECHT6
CONSIGLIO NAZIONALE DELLE RICERCHE5
FUNDACIO PRIVADA INSTITUT D'INVESTIGACIO ONCOLOGICA DE VALLHEBRON5
INSTITUT CATALA D'ONCOLOGIA5
INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE5
INTERNATIONAL AGENCY FOR RESEARCH ON CANCER5
PRINSES MAXIMA CENTRUM VOOR KINDERONCOLOGIE BV5
THE CHANCELLOR MASTERS AND SCHOLARS OF THE UNIVERSITY OF CAMBRIDGE5
UNIVERSITAET ZUERICH5
ACADEMISCH ZIEKENHUIS GRONINGEN4
ASSISTANCE PUBLIQUE HOPITAUX DE PARIS4
FONDAZIONE IRCCS ISTITUTO NAZIONALE DEI TUMORI4
INSTITUT GUSTAVE ROUSSY4
ISTITUTO NAZIONALE PER LO STUDIO E LA CURA DEI TUMORI4
KATHOLIEKE UNIVERSITEIT LEUVEN4
MAX PLANCK GESELLSCHAFT ZUR FOERDERUNG DER WISSENSCHAFTEN EV4
UNIVERSITEIT GENT4
UNIVERSITY OF COPENHAGEN4
UNIVERSITY OF LEEDS4
UNIVERSITY OF OSLO4
UNIVERSITY OF TROMSOE4
UPPSALA UNIVERSITET4
VTT TECHNICAL RESEARCH CENTRE OF FINLAND4
BAYER3
FUNDACIO INSTITUT DE RECERCA BIOMEDICA3
GSF FORSCHUNGSZENTRUM FUER UMWELT UND GESUNDHEIT3
HITS GGMBH3
IBM RESEARCH3
ISTITUTO EUROPEO DI ONCOLOGIA3
KUNGLIGA TEKNISKA HOEGSKOLAN3
LUNDS UNIVERSITET3
MASARYKOVA UNIVERZITA3
MEDIZINISCHE UNIVERSITAT INNSBRUCK3
NATIONAL UNIVERSITY OF IRELAND GALWAY3
OSLO UNIVERSITETSSYKEHUS HF3
ST ANNA KINDERKREBSFORSCHUNG3
THE UNIVERSITY OF WARWICK3
UMEA UNIVERSITET3
UNIVERSIDAD DE NAVARRA3
UNIVERSITA DEGLI STUDI DI MILANO3
UNIVERSITEIT MAASTRICHT3
UNIVERSITY COLLEGE DUBLIN NATIONAL UNIVERSITY OF IRELAND DUBLIN3
UNIVERSITY OF BOLOGNA3
ACADEMIC MEDICAL CENTRE AMSTERDAM2
ALBERT LUDWIGS UNIVERSITAET FREIBURG2
ASOCIACION INSTITUTO BIODONOSTIA2
ASTRAZENECA2
COMMISSARIAT A L'ENERGIE ATOMIQUE2
COMMISSION OF THE EUROPEAN COMMUNITIES DIRECTORATE GENERAL JOINT RESEARCH CENTRE JRC2
CONSORCI INSTITUT D'INVESTIGACIONS BIOMEDIQUES AUGUST PI I SUNYER2
CSC TIETEEN TIETOTEKNIIKAN KESKUS OY2
DANISH CANCER SOCIETY2
DEUTSCHE SPORTHOCHSCHULE KOLN2
DEUTSCHES INSTITUT FUER ERNAEHRUNGSFORSCHUNG2
DRESDEN UNIVERSITY OF TECHNOLOGY2
EMC INFORMATION SYSTEMS INTERNATIONAL UNLIMITED COMPANY2
ETHNIKO KENTRO EREVNAS KAI TECHNOLOGIKIS ANAPTYXIS2
EUROPEAN CANCER ORGANISATION2
EUROPEAN CANCER PATIENT COALITION2
EUROPEAN ORGANISATION FOR RESEARCH AND TREATMENT OF CANCER AISBL2
FORSCHUNGSZENTRUM JULICH2
FOUNDATION FOR GENOMICS & POPULATION HEALTH2
FRAUNHOFER GESELLSCHAFT ZUR FOERDERUNG DER ANGEWANDTEN FORSCHUNG E V2
FUNDACIO INSTITUT D'INVESTIGACIO BIOMEDICA DE BELLVITGE2
FUNDACION CENTRO NACIONAL DE INVESTIGACIONES ONCOLOGICAS CARLOS III2
FUNDACION ONKOLOGIKOA FUNDAZIOA2
FUNDACION PARA LA INVESTIGACION MEDICA APLICADA2
GATC BIOTECH2
GDANSKI UNIWERSYTET MEDYCZNY2
GENETHON2
GOETEBORGS UNIVERSITET2
GROUPEMENT EUROPEEN D INTERET ECONOMIQUE ORGANISATION OF EUROPEAN CANCER INSTITUTES OECI2
HELLENIC HEALTH FOUNDATION2
INSTITUT FUER MOLEKULARE BIOTECHNOLOGIE2
JULIUS CLINICAL RESEARCH BV2
KIO NETWORKS ESPANA2
KLINIKUM DER UNIVERSITAET ZU KOELN2
LUDWIG MAXIMILIANS UNIVERSITAET MUENCHEN2
MEDIZINISCHE UNIVERSITAET WIEN2
NATIONAL UNIVERSITY OF IRELAND MAYNOOTH2
NORGES MILJOOG BIOVITENSKAPLIGE UNIVERSITET2
NUROGAMES2
POLYTECHNIC OF MILAN2
RIJKSINSTITUUT VOOR VOLKSGEZONDHEIDEN MILIEUNATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT2
SERVICIO MADRILENO DE SALUD2

Constancy:

Total number of partners: 897
Partner loyalty:
Frequent Partner: (> 2 projects): 280
Rare Partner: 617
Frequent / Rare Partner Ratio: 0.45

Project overview:

Start dateProjectacronymrolefundingpartners
2023-01-01Understanding the complex biology of AHR activation in cancer CancAHRcoordinator1.999.9251
2023-01-01Decoding Requirements for Infiltration of T ceLLs into solid tumors DRILLcoordinator1.521.0001
2023-01-01Understanding Lung Cancer related risk factors and their Impact LUCIAparticipant13.516.86922
2023-01-01From Caterpillar to BUTTERFLY: supporting transformation of DCs in a paediatric oncology network Maxima Butterflyparticipant3.763.20036
2023-01-01Extreme Near-Data Processing Platform NEARDATAparticipant3.913.58511
2023-01-01Adaptive virtualization for AI-enabled Cloud-edge Continuum CloudSkinparticipant3.405.32312
2023-01-01Quality of Life in Oncology: measuring what matters for cancer patients and survivors in Europe EUonQoLparticipant10.607.31127
2022-12-01Novel health care strategies for melanoma in children, adolescents and young adults MELCAYAparticipant8.013.21925
2022-11-01PREFERABLE-II - Personalised Exercise-Oncology for improvement of supportive care: a super umbrella trial to demonstrate the (cost)effectiveness of live-remote exercise in cancer survivors PREFERABLE-IIparticipant5.925.46314
2022-11-01Imaging and Characterization for a Sustainable World I4WORLDparticipant3.360.00036
2022-10-01nanoVAST: a novel, non- viral LNP for precision payload delivery of genome editors and other cargo nanoVASTcoordinator150.0002
2022-10-01Investigation on the vaccination potential of IL4i1 deficient dendritic cells in Chronic lymphocytic leukemia engineereD to Clearcoordinator189.6871
2022-10-01TWINNING OF MAGNETIC RESONANCE IMAGING RESEARCH INSTITUTES MRITwinsparticipant1.375.0005
2022-09-01Deciphering immune evasion of Acute Myeloid Leukemia DIEAMLcoordinator162.8061
2022-09-01A European-wide foundation to accelerate Data-driven Cancer Research EOSC4Cancerparticipant7.814.54934
2022-07-01Decoding consequences of complex chromosomal aberrations by multi-modal single-cell deconstruction to overcome treatment-resistance cancer SHATTER-AMLcoordinator2.499.3751
2022-06-01Developing novel inhaled bioengineered Extracellular Vesicle RNA based advanced therapeutics, delivered by tailored aerosol delivery technology for the treatment of lung cancer INSPIREparticipant12.778.5958
2022-06-01Skeletal Muscles Antagonize T Cell Exhaustion in Chronic Viral Infections MuscleAntiViruscoordinator2.000.0001
2022-05-01MIRACLE the platform for virtual biopsies; introducing Metabolic MRI-as-a-Service for oncologic care MIRACLEparticipant2.495.1274
2021-09-01Trafficking of Wnt Signaling Components in Cancer TWSCCcoordinator162.8061
2021-07-01Impact of RNA modifications on neuronal fate Rn7SKmodcoordinator162.8061
2021-05-01Neural Spectral Image Decoding NEURAL SPICINGcoordinator1.999.9751
2021-04-10Single Cell EPigenomic, Transcriptomic, and structural Rearrangement profiling to investigate Evolution in prostate cancer SCEPTREcoordinator174.8061
2021-03-01AN IN VIVO BIOENGINEERED CHIP AS A SMART INTRAVITAL MULTIPHOTON IMAGING WINDOW FOR NEW VALIDATION PROTOCOLS OF BIOMATERIALS IN2SIGHTparticipant3.438.9598
2021-02-01Building Data Rich Clinical Trials CCE_DARTparticipant5.999.41112
2021-01-01Dissecting the Functional and Therapeutic Impact of Somatic Copy Number Alterations (SCNAs) CrispSCNAsparticipant1.500.0002
2021-01-01DNA Breaks Shape Neural Genome Heterogeneity BrainBreakscoordinator1.500.0001
2020-12-01ROles of ePitranscriptomic in diseasES ROPESparticipant3.095.82911
2020-12-01Validation of Actionable Genomic ABerrations in a paediatric Oncology Network for Doctorate students VAGABONDparticipant3.989.71312
2020-08-01Fatty liver Nano-/Antibody Therapy - (FAITH) FAITHcoordinator150.0001
2020-07-01Generating monoclonal antibodies that selectively and specifically recognize epitranscriptomic modifications. EPIMODKITcoordinator150.0002
2020-02-01Connect and align ELIXIR Nodes to deliver sustainable FAIR life-science data management services ELIXIR-CONVERGEparticipant9.800.00057
2020-01-014-IN THE LUNG RUN: towards INdividually tailored INvitations, screening INtervals, and INtegrated co-morbidity reducing strategies in lung cancer screening 4-IN THE LUNG RUNparticipant7.999.94910
2020-01-01HCA|Organoid: Pilot action to establish a multi-tissue human organoid platform within the Human Cell Atlas as a booster of future disease-centric, mechanistic, and translational research HCA Organoidparticipant4.998.6888
2019-09-01CTCF control of genome stability in ageing CTCFStableGenomecoordinator2.488.2511
2019-07-01Decoding Context-Dependent Genetic Networks in vivo DECODEcoordinator10.625.0003
2019-06-01The strong interaction at the frontier of knowledge: fundamental research and applications STRONG-2020participant10.000.00045
2019-05-01Matching CNS Lineage Maps with Molecular Brain Tumor Portraits for Translational Exploitation BRAIN-MATCHcoordinator1.999.8751
2019-03-01European network staff eXchange for integrAting precision health in the health Care sysTems ExACTparticipant1.090.20018
2019-02-01European Advanced infraStructure for Innovative Genomics EASI-Genomicsparticipant9.991.26716
2019-02-01Safeguarding Cell Fate by Terminal Repression during Development and Disease SafeFatecoordinator1.761.4891
2019-01-24Clarifying role of the CENTROSOME in abnormal mitotic processes featuring the most commonchildhood malignancy: paediatric High Hyperdiploid Acute Lymphoblastic Leukaemia (HHDpALL) CENTR-ALLcoordinator171.4611
2019-01-01Translational studies of HEAD and neck cancer in South America and Europe HEADSpAcEparticipant3.153.44818
2019-01-01ARCHITECTURE AND TOOLS FOR THE QUERY OF ANTIBODY AND T-CELL RECEPTOR SEQUENCING DATA REPOSITORIES FOR ENABLING IMPROVED PERSONALIZED MEDICINE AND IMMUNOTHERAPY iReceptor Plusparticipant7.856.92520
2019-01-01Project on Exercise for Fatigue Eradication in Advanced Breast cancer to improve quality of life PREFERABLEparticipant3.983.34712
2019-01-01individualizedPaediatricCure: Cloud-based virtual-patient models for precision paediatric oncology iPCparticipant14.748.40021
2019-01-01EUCANCan: a federated network of aligned and interoperable infrastructures for the homogeneous analysis, management and sharing of genomic oncology data for Personalized Medicine. EUCANCanparticipant5.999.45318
2019-01-01Targeting genetic and epigenetic mechanisms in pediatric sarcomas. PedSarccoordinator1.499.3751
2018-09-01Quantitative T cell Immunology and Immunotherapy QuanTIIparticipant3.923.65311
2018-08-01Mechanisms of vascular maturation and quiescence during development, homeostasis and aging AngioMatureparticipant2.338.9182

overview shows latest 50 from 118 projects (2010-01-01 - 2024-12-31)
A full list of projects can be found here:

Alias institution names:

  • DEUTSCHES KREBSFORSCHUNGSZENTRUM
  • DEUTSCHES KREBSFORSCHUNGSZENTRUM HEIDELBERG